Fact sheet: SW Schr Gbl Healthcare Pn

Fund information
Fund name
SW Schroder Global Healthcare Pension Series 2
Fund manager company
Scottish Widows Limited
Fund type
Pension Fund
Fund managers
  • John Bowlersince 31/03/2004
Underlying fund
Schroder Global Healthcare
Fund objective
The fund aims for long-term growth by investing in healthcare, medical services and related companies. It invests world-wide, but as over half the world’s healthcare companies are headquartered in the US this market is likely to make up the largest part of the portfolio. Investment is solely through the Schroder Medical Discovery Unit Trust.
Benchmark
  • MSCI World Healthcare
Investment style
No data available.
Investment method
No data available.
Quick stats
1 Year return
19.6%
1 Year rank in sector
198/531
Sector
PN Specialist
Yield
-
Fund size
£3m (£3m last year)
FE Risk score
?FE Risk Scores measure the riskiness of instruments relative to the FTSE 100 index of shares. Weekly volatility is measured over three years with recent behaviour counting more heavily than earlier behaviour. Cash-type investments will have scores close to zero. Funds will tend to have scores in the 0-150 range. The FTSE 100 is always scored at 100. There is no upper limit.
128
Bid price
309.6
Offer price
309.6
Top in this sector
Fund name1 Year
Scot Eq Technology Pn57.9%
SIP Fidelity Gbl Technology Pn56.4%
FL AXA Framlington Gbl Tech AP54.9%
Zurich AXAFramGblTechPn53.9%
OMW AXA Framlington Gbl Tech53.7%
...more in PN Specialist

Performance snapshot

Holdings snapshot

  • USA66.3%
    Switzerland8.4%
    Germany4.1%
    UK3.6%
    Japan3.4%
  • Health Care89.4%
    Basic Materials4.1%
    Money Market2.8%
    Industrials1.9%
    Consumer Services1.3%
  • US Equities66.3%
    Swiss Equities8.4%
    German Equities4.1%
    UK Equities3.6%
    Japanese Equities3.4%

Performance vs Sector

Cumulative performance
 1 mth3 mth6 mth1 yr3 yr5 yr
Fund2.3%1.8%7.8%19.6%52.7%137.8%
Sector1.3%1.9%6.3%15.2%25.7%50.1%
Rank within sector60 / 554254 / 554200 / 549198 / 53139 / 39516 / 333
Quartile1st2nd2nd2nd1st1st
Calendar performance
 YTD - 20172016201520142013
Fund6%9.8%9.6%26.6%35.9%
Sector4%11.6%2%7.2%11%
Rank within sector89 / 550263 / 51432 / 44917 / 3878 / 360
Quartile1st3rd1st1st1st
Risk statistics
Alpha
?Alpha is a measure of a fund's over- or under-performance by comparison to its benchmark. If the Alpha is 5, the fund has outperformed its benchmark by 5%; so the greater the Alpha, the greater the outperformance.
1.66
Beta
?Beta estimates a fund's volatility by comparison to that of its benchmark. A fund with a beta close to 1 means that the fund will move generally in line with the benchmark. Higher than 1 and the fund is more volatile than the benchmark and vice versa.
1.72
Sharpe
?This commonly-used measure calculates the level of return over and above the return of a notional risk-free investment, such as cash. The difference in returns is then divided by the fund's volatility. The resulting ratio is an indication of the amount of excess return generated per unit of risk.
0.85
Volatility
?Volatility (or standard deviation), when applied to an investment fund, expresses its risk. It shows how widely a range of returns varied from the fund's average return over a particular period. For example, if a fund had an average return of 5%, and its volatility was 15, this would mean that the range of its returns over the period had swung between +20% and -10%.
13.52
Tracking error
?This measures the standard deviation of a fund's excess returns over the returns of an index or benchmark portfolio. As such, it can be an indication of 'riskiness' in the manager's investment style. A Tracking Error below 2 suggests a passive approach. At 3 and above the the manager will be deploying a more active investment style.
9.8
Information ratio
?This is a useful risk-adjusted measure of actively managed fund performance. It is calculated by deducting the returns of the fund's benchmark from the fund's overall returns, then dividing the result by its tracking error. The higher the Information Ratio the better. It is generally considered that a figure of 0.5 reflects a good performance, 0.75 very good, and 1.00 outstanding.
0.68
R-Squared
?An indication of how closely correlated a fund is to an index or a benchmark. Values for R-Squared range between 0 and 1, with 0 indicating no correlation at all and 1 showing a perfect match. Values upwards of 0.7 suggest that the fund's behaviour is increasingly linked to its benchmark.
0.56
Price movement
52 week high320.5
52 week low256.9
Current bid price309.6
Current offer price309.6
Current mid price-
Region
1USA66.26%
2Switzerland8.4%
3Germany4.08%
4UK3.56%
5Japan3.35%
6Denmark3.24%
7Money Market2.83%
8Sweden1.99%
9Belgium1.81%
Industry sector
1Health Care89.41%
2Basic Materials4.08%
3Money Market2.83%
4Industrials1.88%
5Consumer Services1.26%
6Technology0.54%
Asset type
1US Equities66.26%
2Swiss Equities8.4%
3German Equities4.08%
4UK Equities3.56%
5Japanese Equities3.35%
6Danish Equities3.24%
7Money Market2.83%
8Swedish Equities1.99%
9Belgian Equities1.81%
Individual holdings
1UNITEDHEALTH GROUP INC5.81%
2JOHNSON & JOHNSON5.47%
3ROCHE HLDG AG5.22%
4MERCK & CO INC(NEW)4.43%
5BAYER AG4.08%
6MEDTRONIC PLC3.86%
7AMGEN INC3.85%
8ALLERGAN PLC3.66%
9LILLY (ELI) & CO3.38%
Management
Fund manager group
Scottish Widows
Fund manager company
Scottish Widows Limited
Fund type
Pension Fund
Fund objective
The fund aims for long-term growth by investing in healthcare, medical services and related companies. It invests world-wide, but as over half the world’s healthcare companies are headquartered in the US this market is likely to make up the largest part of the portfolio. Investment is solely through the Schroder Medical Discovery Unit Trust.
Benchmark
  • MSCI World Healthcare
Investment style
No data available.
Investment method
No data available.
Fund managers
NameSinceBiography
John Bowler31/03/2004John Joined Schroders in 2003.Investment career commenced in 1994.Currently Global Sector Specialist with responsibility for the healthcare sector and manager of the Schroder Medical Discovery Fund, as well as having primary research responsibility for Pan-European pharmaceuticals. Based in London John joined Schroders from AXA Investment Managers, where he had worked since 1998 in a global healthcare research role. He was voted top buy-side analyst for the pharmaceutical and healthcare sector in the Institutional Investor Pan European Equity survey in 2002.Before this, John worked at State Street Research & Management from 1997 as a fund manager / analyst.Earlier, John joined Hill Samuel Asset Management in 1994 as a graduate trainee, later becoming a junior fund manager for UK equities.Institute of Investment Management and Research (IIMR) qualified. Member of the CFA Society of the UK (CFA UK). PhD in Biochemistry & Physiology, from the University of Manchester. Degree in Biology from the University of Manchester.
Compliance
No data available.
Domicile
No data available.
Fund for sale in
United Kingdom
SW Schroder Global Healthcare Pension Series 1
Initial charge-
Annual charge0.88%
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)1.82%
Total expense ratio (TER)1.8%
Bid price299.9
Offer price315.7
Mid price-
CurrencyGBX
Price updated25/05/2017
Type-
Institutional or retail classRetail
Domicile-
Citi codeSF89
SW Schroder Global Healthcare Pension Series 2
Initial charge-
Annual charge1%
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)1.94%
Total expense ratio (TER)1.92%
Bid price309.6
Offer price309.6
Mid price-
CurrencyGBX
Price updated25/05/2017
Type-
Institutional or retail classRetail
Domicile-
Citi codeSF88
SW Schroder Global Healthcare Pension Series 4
Initial charge-
Annual charge0.95%
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)1.14%
Total expense ratio (TER)1.12%
Bid price355.7
Offer price355.7
Mid price-
CurrencyGBX
Price updated25/05/2017
TypeAccumulation
Institutional or retail classRetail
Domicile-
Citi codeE478
Data provided by

The Content is only for your general information and use and is not intended to address your particular requirements. The Content does not constitute any form of advice, recommendation or arrangement by Moneywise and is not intended to be relied upon by you in making (or refraining from making) any specific investment or other decisions. Appropriate independent advice should be obtained before making any such decision.

This information is sourced from our partner Financial Express. We believe the data to be correct however you should take care in using any information.

You should be aware that prices may fall as well as rise and that the income derived can go down as well as up. When buying or selling any investment that fluctuates in price or value you may get back less than you invested. Past performance is not necessarily a guide to future performance.